Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease
2011/09/21 by Laurent Peyrin-Biroulet, Laurent Peyrin‐Biroulet, Florent Gonzalez +14 · 25 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Inflammatory Bowel Disease #Inflammation biomarkers and pathways #Inflammatory Biomarkers in Disease Prognosis
paper · pdf · doi:10.1136/gutjnl-2011-300370
Abstract
OBJECTIVE: Mesenteric fat hyperplasia is a hallmark of Crohn's disease (CD), and C reactive protein (CRP) is correlated with disease activity. The authors investigated whether mesenteric adipocytes may be a source of CRP in CD and whether inflammatory and bacterial triggers may stimulate its production by adipocytes. DESIGN: CRP expression in the mesenteric and subcutaneous fats of patients with CD and the correlation between CRP plasma concentrations and mesenteric messenger RNA (mRNA) levels were assessed. The impact of inflammatory and bacterial challenges on CRP synthesis was tested using an adipocyte cell line. Bacterial translocation to mesenteric fat was studied in experimental models of colitis and ileitis and in patients with CD. RESULTS: CRP expression was increased in the mesenteric fat of patients with CD, with mRNA levels being 80 ± 40 (p<0.05) and 140 ± 65 (p=0.04) times higher than in the mesenteric fat of patients with ulcerative colitis and in the subcutaneous fat of the same CD subjects, respectively, and correlated with plasma levels. Escherichia coli (1230 ± 175-fold, p<0.01), lipopolysaccharide (26 ± 0.5-fold, p<0.01), tumour necrosis factor α (15 ± 0.3-fold, p<0.01) and interleukin-6 (10 ± 0.7-fold, p<0.05) increased CRP mRNA levels in adipocyte 3T3-L1 cells. Bacterial translocation to mesenteric fat occurred in 13% and 27% of healthy and CD subjects, respectively, and was increased in experimental colitis and ileitis. Human mesenteric adipocytes constitutively expressed mRNA for TLR2, TLR4, NOD1 and NOD2. CONCLUSION: Mesenteric fat is an important source of CRP in CD. CRP production by mesenteric adipocytes may be triggered by local inflammation and bacterial translocation to mesenteric fat, providing a mechanism whereby mesenteric fat hyperplasia may contribute to inflammatory response in CD.
Citations
Cited by
- Adipose tissue and inflammatory bowel disease pathogenesis. [europepmc]
- Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. [europepmc]
- Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. [europepmc]
- Microbiota-Dependent Sequelae of Acute Infection Compromise Tissue-Specific Immunity. [europepmc]
- Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. [europepmc]
- The Role of the Microbiota in Shaping Infectious Immunity. [europepmc]
- Linking the Microbiota, Chronic Disease, and the Immune System. [europepmc]
- Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. [europepmc]
- Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. [europepmc]
- The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces. [europepmc]
- Anatomical, Physiological, and Functional Diversity of Adipose Tissue. [europepmc]
- Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis. [europepmc]
- The Human Mesenteric Lymph Node Microbiome Differentiates Between Crohn's Disease and Ulcerative Colitis. [europepmc]
- Adipokines and Their Role in Intestinal Inflammation. [europepmc]
- Mechanisms and consequences of gut commensal translocation in chronic diseases. [europepmc]
- Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. [europepmc]
- Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. [europepmc]
- Role of Adipose Tissue in Inflammatory Bowel Disease. [europepmc]
- FOXC2 controls adult lymphatic endothelial specialization, function, and gut lymphatic barrier preventing multiorgan failure. [europepmc]
- Dysbiotic microbiota interactions in Crohn's disease. [europepmc]
- Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. [europepmc]
- The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease. [europepmc]
- Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. [europepmc]
- IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. [europepmc]
- Microbiota-gut-brain axis: interplay between microbiota, barrier function and lymphatic system. [europepmc]
Related